You just clicked a link to go to another website. If you continue, you may go to a site run by someone else.
It is possible that some of the products on the other site are not approved in your region or country.
Your browser is out of date
With an updated browser, you will have a better Medtronic website experience. Update my browser now.
The content of this website is exclusively reserved for Healthcare Professionals in countries with applicable health authority product registrations.
Click “OK” to confirm you are a Healthcare Professional.
Imagine fewer trips to the bathroom. Fewer accidents. And resuming the relationships and activities you love.
That’s why more conservative treatments may not produce the results you want — they don’t target the miscommunication between your bowel and brain. Bowel Control Therapy delivered by a sacral neuromodulation system is thought to correct the bowel-brain communication pathway to help control the symptoms of chronic FI.
Implanting a neurostimulator has risks similar to any surgical procedure, including swelling, bruising, bleeding, and infection. Talk with your doctor about ways to minimize these risks.
The most common adverse events were: implant site pain, paresthesia, change in sensation of stimulation, implant site infection, urinary incontinence, neurostimulator battery depletion, diarrhea, pain in extremity, undesirable change in stimulation, and buttock pain.
You may be a good candidate for Bowel Control Therapy if:
Unlike other bowel control treatments, Bowel Control Therapy lets you try it first. It’s called an evaluation — like a test run, not a long-term commitment.
Complications can occur with the evaluation, including movement of the wire, technical problems with the device, and some temporary pain. Your doctor or nurse will show you how to use the system, and inform you of any activity restrictions and other precautions related to the evaluation.
I've been able to fully embrace the activities I love.- Judy M. Experiencing relief with Bowel Control Therapy delivered by sacral neuromodulation
Success defined as ≥ 50% reduction of episodes/week. This patient group had data at both baseline and the 5 year visit. Another analysis reported 69% of people achieved success with Bowel Control Therapy. For this patient group, missing data at 5 years because of a device-related reason was counted as failure or if it was missing for non-device related reasons, the most recent data was carried forward.
Hull T, Giese C, Wexner SD, et al. Long-term Durability of Sacral Nerve Stimulation Therapy for Chronic Fecal Incontinence. Dis Colon Rectum. 2013; 56(2):234-45.
Tjandra JJ, Chan MKY, Yeh CH, Murray-Green C. Sacral nerve stimulation is more effective than optimal medical therapy for severe fecal incontinence: a randomized, controlled study. Dis Colon Rectum. 2008;51(5):494-502.